Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
AstraZeneca
Daiichi Sankyo
Cerilliant
Covington
Farmers Insurance
Fuji
McKinsey
Julphar

Generated: February 21, 2019

DrugPatentWatch Database Preview

Kv Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for KV PHARM, and what generic and branded alternatives to KV PHARM drugs are available?

KV PHARM has forty-eight approved drugs.



Summary for Kv Pharm
US Patents:0
Tradenames:26
Ingredients:26
NDAs:48
Patent Litigation for Kv Pharm: See patent lawsuits for Kv Pharm

Drugs and US Patents for Kv Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kv Pharm PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 084138-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Kv Pharm PREDNISONE prednisone TABLET;ORAL 084236-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Kv Pharm METHOCARBAMOL methocarbamol TABLET;ORAL 085658-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Kv Pharm ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate TABLET;ORAL 085364-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Kv Pharm HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride TABLET;ORAL 087820-001 Jun 23, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Kv Pharm CHLORPROMAZINE HYDROCHLORIDE chlorpromazine hydrochloride TABLET;ORAL 085748-002 Jan 4, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Kv Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Kv Pharm MICRO-K LS potassium chloride FOR SUSPENSION, EXTENDED RELEASE;ORAL 019561-003 Aug 26, 1988 4,259,315 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Covington
Cerilliant
McKesson
Federal Trade Commission
Teva
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.